Mastercard and Gilead Partner to Simplify Delivery of Hepatitis Treatment in Pakistan

Oct 1, 2018 6:00 PM ET

Last year, in partnership with Mastercard and the World Hepatitis Alliance, we launched a pilot program in Pakistan to simplify the delivery of HCV treatment in a resource-limited setting with high disease burden.

Learn more in the video above.

Mastercard and Gilead Partner to Simplify Delivery of Hepatitis Treatment in Pakistan

More from Gilead Sciences

Gilead Helps Pen a Children’s Book for Families Facing Breast Cancer

Gilead Foundation’s Healthcare Education, Access and Leadership (HEAL) Initiative Is Dedicating $5 Million to Help Build a More Diverse Bay Area Healthcare Workforce

Gilead Oncology Grant Supports 22 U.S. Organizations With $3.15 Million to Provide Support to Those Affected By Breast Cancer

Gilead Sciences: New Report Shows Every Country in the World Must Do More To End the HIV Epidemic

Championing HIV Services for LGBTQ+ Youth

Working to Build Next-Generation Cancer Therapies

Helping End HIV - Gilead Sciences

Seramount Ranks Gilead Sciences Among Its Leading Inclusion Index Company